Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Janus

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Nature Medicine|October 16, 2002
Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesisJ McLaurin, R Cecal, M E Kierstead, et al.
The Journal of Biological Chemistry|March 30, 2001
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695M A Chishti, D S Yang, C Janus, et al.
Nature Medicine|February 4, 1999
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complexM Nishimura, G Yu, G Levesque, et al.
Nature|September 19, 2000
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processingG Yu, M Nishimura, S Arawaka, et al.
Neurobiology of Disease|July 28, 2010
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceH L Melrose, J C Dächsel, B Behrouz, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Nature Medicine|October 16, 2002
Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesisJ McLaurin, R Cecal, M E Kierstead, et al.
The Journal of Biological Chemistry|March 30, 2001
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695M A Chishti, D S Yang, C Janus, et al.
Nature Medicine|February 4, 1999
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complexM Nishimura, G Yu, G Levesque, et al.
Nature|September 19, 2000
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processingG Yu, M Nishimura, S Arawaka, et al.
Neurobiology of Disease|July 28, 2010
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceH L Melrose, J C Dächsel, B Behrouz, et al.
Pageof 7